Variant report
Variant | nsv980579 |
---|---|
Chromosome Location | chr5:100896196-100906743 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538429068 | chr5:100896425-100896426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs556764225 | chr5:100896477-100896478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs536595128 | chr5:100896498-100896499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371454055 | chr5:100896553-100896554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs144493140 | chr5:100896579-100896580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs558664171 | chr5:100896628-100896629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs146556202 | chr5:100896657-100896658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs373769790 | chr5:100896732-100896733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs540238295 | chr5:100896758-100896759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs10040426 | chr5:100896781-100896782 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs182509647 | chr5:100896814-100896815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545601118 | chr5:100896823-100896824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563910878 | chr5:100896833-100896834 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531224925 | chr5:100896853-100896854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541254564 | chr5:100896879-100896880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542914472 | chr5:100896888-100896889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568671144 | chr5:100897016-100897017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs113221296 | chr5:100897028-100897029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs397998863 | chr5:100897036-100897037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371417557 | chr5:100897037-100897038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs528449742 | chr5:100897084-100897085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs73780345 | chr5:100897145-100897146 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs531992604 | chr5:100897191-100897192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs565024450 | chr5:100897330-100897331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs532511868 | chr5:100897363-100897364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs367686782 | chr5:100897378-100897379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550358375 | chr5:100897382-100897383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs117097107 | chr5:100897406-100897407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs536050865 | chr5:100897445-100897446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs548149857 | chr5:100897448-100897449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566779657 | chr5:100897460-100897461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs574654625 | chr5:100897502-100897503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533531433 | chr5:100897543-100897544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558555335 | chr5:100897557-100897558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs187101187 | chr5:100897560-100897561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs114293186 | chr5:100897592-100897593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190708131 | chr5:100897595-100897596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs575876375 | chr5:100897663-100897664 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs563532303 | chr5:100897709-100897710 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs575599727 | chr5:100897762-100897763 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs543229860 | chr5:100897773-100897774 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs57706967 | chr5:100897795-100897796 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs141192827 | chr5:100897828-100897829 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs540256906 | chr5:100897845-100897846 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs528206386 | chr5:100897920-100897921 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182667292 | chr5:100897960-100897961 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs200106983 | chr5:100898014-100898015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs57313564 | chr5:100898028-100898029 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs17137203 | chr5:100898078-100898079 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs115713198 | chr5:100898119-100898120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:100896400-100897400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
2 | chr5:100896600-100897600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr5:100897000-100897600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr5:100897200-100897600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr5:100897200-100898000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr5:100897600-100898600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
7 | chr5:100898800-100899000 | Enhancers | HUES48 Cell Line | embryonic stem cell |